title: Recent Patents on Thiazole Derivatives Endowed with Antitumor Activity.
abstract: Cancer is a disease of remarkable importance in the world today and is projected to become the primary cause of death within the coming years, therefore the design and development of new antitumor agents is one of the most pressing research areas in medicinal chemistry. Considering the importance of thiazole ring as scaffold present in a wide range of therapeutic agents, the medicinal chemists have been encouraged to synthesize a large number of novel antitumors bearing this heterocycle, which furnish extensive synthetic possibilities due to the presence of several reaction sites. The present review describes the patents from 2008 to present concerning new thiazole compounds useful for the development of new drug molecules. It has been divided according to the molecular target and describes the pathways involved in the biological activities and the structure of the most potent compounds, together with the screening results.
authors.forename: Rita
authors.initials: R
authors.lastname: Morigi
authors.forename: Alessandra
authors.initials: A
authors.lastname: Locatelli
authors.forename: Alberto
authors.initials: A
authors.lastname: Leoni
authors.affiliation: Dipartimento di Farmacia e Biotecnologie FaBiT, Universita di Bologna, Via Belmeloro, 6. Bologna- 40126, Italy. mirella.rambaldi@unibo.it.
authors.forename: Mirella
authors.initials: M
authors.lastname: Rambaldi
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D055808:Drug Discovery; D006801:Humans; D020782:Matrix Metalloproteinases / Q000187:drug effects; D009369:Neoplasms / Q000188:drug therapy; D010330:Patents as Topic; D013329:Structure-Activity Relationship; D013844:Thiazoles / Q000494:pharmacology / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D013844:Thiazoles; D020782:Matrix Metalloproteinases